论文部分内容阅读
背景已知抗凝治疗中出血的危险因子与预告心房颤动(AF)病人血栓栓塞事件的危险因子相同。本研究探讨病人如何最大限度地避免脑溢血和出血。方法和结果《Swedish Hospital Discharge Register》登记的182 673例AF病人均观察1.5年(危险为260 000人-年)。据登记时填写历史沿用的internal classification of disease的诊断编码,用药情况得自Swedish Drug Registry。第一终点是净裨益
Background The known risk factors for bleeding in anticoagulant therapy are the same as for risk factors for thromboembolic events in patients with atrial fibrillation (AF). This study explored how patients can minimize stroke and bleeding. Methods and Results A total of 182 673 AF patients enrolled in the Swedish Hospital Discharge Register were observed for 1.5 years (260 000 person-years at risk). According to the history of registration, fill in the history of the internal classification of disease diagnostic codes, medication from the Swedish Drug Registry. The first end is a net benefit